# BioRestorative Therapies, Inc. (BRTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/BRTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 23.2K | $ -2.15M | $ -3.81M | $ 34.5K | $ 3.03M |
| 2025 | $ 368.3K | $ -14.58M | $ -11.17M | $ 0 | $ 356.7K |
| 2024 | $ 421.5K | $ -9.44M | $ -8.76M | $ 0 | $ 8.53M |
| 2023 | $ 157.6K | $ -7.51M | $ -7.34M | $ 162.3K | $ 10.00M |
| 2022 | $ 133.8K | $ -20.66M | $ -7.05M | $ 301.6K | $ 10.29M |
| 2021 | $ 54.7K | $ -52.66M | $ -3.99M | $ 670.7K | $ 21.60M |
| 2020 | $ 98.1K | $ -14.36M | $ -2.50M | $ 4.79M | $ -1.33M |
| 2019 | $ 167.8K | $ -18.91M | $ -9.01M | $ 7.84M | $ -12.78M |
| 2018 | $ 146.6K | $ -16.53M | $ -6.78M | $ 4.15M | $ -8.64M |
| 2017 | $ 109.1K | $ -12.72M | $ -5.20M | $ 3.66M | $ -6.84M |
| 2016 | $ 50.0K | $ -11.88M | $ -7.14M | $ 2.16M | $ -5.00M |
| 2015 | $ 883.0K | $ -11.12M | $ -5.06M | $ 1.31M | $ -3.91M |
| 2014 | $ 587.8K | $ -7.90M | $ -4.80M | $ 5.74M | $ -6.89M |
| 2013 | $ 2.4K | $ -8.18M | $ -3.82M | $ 5.51M | $ -6.69M |
| 2012 | $ 22.5K | $ -9.44M | $ -4.63M | $ 4.56M | $ -5.14M |
| 2011 | $ 0 | $ -5.99M | $ -4.20M | $ 3.04M | $ -3.69M |
| 2010 | $ 0 | $ -2.42M | $ -499.1K | $ 710.9K | $ -744.2K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.53 |
| Current Ratio | 2.35 |

## Other views

- [Metrics](https://sponda.capital/en/BRTX.md)
- [Charts](https://sponda.capital/en/BRTX/charts.md)
- [Compare](https://sponda.capital/en/BRTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.